Multiple Myeloma Life Expectancy With Stem Cell Transplant

The long term survival of people with multiple myeloma following autologous stem cell transplant has steadily improved since 1997 through with the introduction of new medicines a large review.

Multiple myeloma life expectancy with stem cell transplant.

Multiple myeloma isn t considered curable but symptoms wax and wane. This type of transplant is a conventional treatment for patients with multiple myeloma. A stem cell transplant replaces diseased stem cells with healthy ones and is often used to treat this form of cancer. This is outstanding progress in that life expectancy had been stagnant at 4 years for 5 consecutive years.

A person with multiple myeloma is likely to have a low blood count. Although an autologous transplant can make the myeloma go away for a time even years it doesn t cure the cancer and often the myeloma returns. Studies show that this can benefit more patients than when a single transplant. Multiple myeloma life expectancy after stem cell transplant a 65 year old male asked.

Advances in biotechnology have allowed scientists to identify several genetic and chromosomal abnormalities. Call this method transplant tandem. Stem cell transplant for multiple myeloma life expectancy multiple myeloma stem cell transplant survival rate stem cell transplant for multiple myeloma if there is a disease which most clearly demonstrates the recent improvements in the treatment of cancer is multiple myeloma. Some doctors recommend that patients with multiple myeloma have 2 autologous transplants 6 to 12 months apart.

This approach is called tandem transplant. In some cases a bone marrow or stem cell transplant is an option. Some doctors recommend that patients with multiple myeloma undergo two autologous transplants apart for six to 12 months. There can be a long period of dormancy that could last.

In the last two years the average life expectancy has gone from 4 years to 5 5 years according to the seer surveillance epidemiology and end results data for multiple myeloma published in april of 2017 by the national cancer institute. Five year survival for multiple myeloma patients given asct has grown from 47 in 1997 or earlier to 70 in those treated in 2014 or later a study found. My cousin is 64yrs old and has end stage multiple myeloma he had a autologous stem cell transplant 7 months ago he was put on a light maintenance chemo pill and now he is taking out patient chemo again.